Core Viewpoint - Alpine Income Property Trust, Inc. will report its financial and operating results for Q1 2026 on April 23, 2026, with a conference call scheduled for April 24, 2026 [1][2]. Company Overview - Alpine Income Property Trust, Inc. is a publicly traded real estate investment trust (REIT) focused on delivering attractive risk-adjusted returns and dependable cash dividends by investing in single tenant net leased commercial income properties, primarily leased to high-quality publicly traded and credit-rated tenants [3]. - The company also strategically invests in a select portfolio of commercial loan investments to enhance its income property portfolio and achieve attractive risk-adjusted returns [3].

Core Viewpoint - NurExone Biologic Inc. has established Exo-Top Inc. as a strategic U.S. subsidiary to enhance its manufacturing, clinical advancement, and long-term value creation in the biotechnology sector focused on exosome-based therapies [1][2]. Group 1: Exo-Top Sublicense Agreement - NurExone Ltd. has granted Exo-Top certain rights under an exclusive worldwide development and commercialization license with Technion Research and Development Foundation Ltd. and Ramot, which is aimed at supporting future manufacturing and commercial activities for naïve exosomes in the U.S. [1][2] - The Exo-Top Sublicense is expected to enhance strategic flexibility in the U.S. market, aligning with NurExone's long-term strategy [2][3]. Group 2: Strategic Importance of Exo-Top - Exo-Top is positioned as a key component of NurExone's North American strategy, focusing on manufacturing, development, and commercialization of exosome-based therapeutics [4][5]. - One of Exo-Top's critical assets is its Master Cell Bank, which ensures batch-to-batch consistency essential for clinical translation and commercial readiness [4]. Group 3: Financial Obligations and Expectations - Under the Tech License, NurExone is obligated to pay certain royalty fees upon reaching Phase II of clinical trials and additional royalties upon commercialization, but no monetary consideration was paid by Exo-Top to NurExone Ltd. for the sublicense [3][5]. - The company does not anticipate any sublicense fees to be payable to TRDF in connection with the Exo-Top Sublicense execution [3].

Core Viewpoint - Galapagos NV has proposed the appointment of Gino Santini as a Non-Executive Independent Director and intends to appoint him as Chair of the Board, subject to shareholder approval at the upcoming Annual Shareholders' Meeting on April 28, 2026 [1][2]. Group 1: Leadership Transition - Gino Santini will succeed Jérôme Contamine as Chair of the Board, whose term ends immediately after the AGM [2]. - The CEO of Galapagos, Henry Gosebruch, expressed confidence in Santini's operational and strategic expertise, which is expected to be crucial for the company's future growth and value creation [3]. - Jérôme Contamine acknowledged the transformative period for Galapagos during his tenure and expressed optimism for the company's future under new leadership [3]. Group 2: Gino Santini's Background - Gino Santini has over a decade of governance experience and a 27-year career at Eli Lilly, where he held significant leadership roles [4]. - His expertise includes M&A, commercial partnerships, and board governance, providing him with deep strategic and operational insights [4]. - Santini holds a Mechanical Engineering degree from the University of Bologna and an MBA from the University of Rochester [4]. Group 3: Company Overview - Galapagos is a biotechnology company focused on developing meaningful medicines for patients with serious diseases in areas of unmet need [5]. - The company employs a modality-agnostic asset selection approach and prioritizes oncology and immunology & inflammation programs with clear clinical proof-of-concept [5].

Core Viewpoint - Galapagos NV has published its annual report for the financial year 2025 and announced the scheduling of its Annual Shareholders' Meeting (AGM) and an Extraordinary Shareholders' Meeting (EGM) on April 28, 2026 [1][2] Financial Report - The annual report for the financial year 2025, including a review of figures and performance, is available online and can be downloaded as a PDF [1] - The annual 2025 Form 20-F filing with the SEC is accessible at the SEC's website [1] Shareholders' Meetings - The AGM will take place at 14:00 CET, followed by the EGM at 15:00 CET on April 28, 2026, at Schaliënhoevedreef 20T, 2800 Mechelen, Belgium [2] - The agenda for the AGM includes the appointment of Henry Gosebruch as executive director and several independent non-executive directors, as well as the re-appointment of BDO Bedrijfsrevisoren as the statutory auditor [3] - The EGM agenda includes a proposed name change to Lakefront Biotherapeutics, authorization for share repurchase of up to 10% of outstanding shares, and renewal of the Board's authorization to increase share capital [4] Compliance and Documentation - To attend the AGM and EGM, holders of securities must comply with specific articles of the Belgian Code of Companies and Associations and fulfill formalities described in the convening notice [5] - Additional documents related to the meetings, including biographies of proposed directors, are available on the company's website [5] Company Overview - Galapagos is a biotechnology company focused on developing meaningful medicines for patients with serious diseases, prioritizing oncology and immunology & inflammation programs [6]

Company Overview - Precision Optics Corporation, Inc. is a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, founded in 1982 [5] - The company focuses on leveraging proprietary micro-optics, 3D imaging, and digital imaging technologies to meet the demands of healthcare and defense/aerospace sectors [5] - Precision Optics provides services ranging from new product concept through mass manufacture, utilizing in-house design, prototype, regulatory, and fabrication capabilities [5] Public Offering Announcement - Precision Optics Corporation has announced the commencement of an underwritten public offering of shares of its common stock, subject to market conditions [1] - Lucid Capital Markets is acting as the sole book-running manager for the offering, which is made pursuant to a shelf registration statement filed with the SEC [2] - A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC and made available on the SEC's website [3]

Core Points - Rogers is giving away 500 Opening Night tickets through its Rogers Beyond the Seat program [1] - The company is also offering 225 pairs of tickets to the Home Opener exclusively for Rogers customers at a surprise location [2] - To qualify for the ticket giveaway, customers must show proof of being a Rogers customer through various means [3] - Rogers will continue to give away thousands of tickets throughout the season, including upgrades to 100-level seats [3] - The event details, including the surprise location, will be announced on March 27, 2026 [4] Company Information - Rogers Communications Inc. is a major communications, sports, and entertainment company in Canada, publicly traded on the Toronto Stock Exchange and the New York Stock Exchange [4]

Core Viewpoint - APPlife Digital Solutions, Inc. has announced a strategic partnership with Commerce Pundit Technologies to enhance e-commerce solutions in the automotive aftermarket sector, addressing significant industry challenges [1][4]. Company Overview - APPlife Digital Solutions, Inc. is a business incubator and technology company focused on developing advanced digital solutions and commerce infrastructure [1][8]. - Sugar Auto Parts, a wholly owned subsidiary of APPlife, will lead marketing, customer acquisition, and go-to-market strategy for the joint software solutions [6]. - Commerce Pundit Technologies is a full-service web development and digital agency with over 500 developers, specializing in various e-commerce platforms [2][5]. Industry Challenges - The automotive parts e-commerce sector faces challenges such as a vast number of individual SKUs, fragmented inventory, inconsistent data systems, and limited technical expertise among participants, leading to poor customer experiences and missed growth opportunities [2][3]. Partnership Objectives - The partnership aims to deliver next-generation e-commerce systems and solutions by combining Sugar Auto Parts' domain expertise with Commerce Pundit's technical capabilities [3][4]. - The collaboration will focus on addressing industry pain points through advanced tools, including intelligent data management systems and AI-driven fitment configurators [7][8]. Financial Arrangement - The parties have agreed to a 50% profit split after deducting operating and marketing expenses from the partnership's revenue [6].

Core Viewpoint - Koil Energy Solutions, Inc. is set to report its fourth quarter and full year 2025 results on March 31, 2026, before market opening, and will host an investor conference call to discuss these results [1]. Company Overview - Koil Energy Solutions, Inc. specializes in deepwater energy production and distribution equipment and services, providing innovative solutions to complex challenges in the energy and offshore industries [3]. - The company's core services include distribution system installation support, engineering services, umbilical terminations, and loose-tube steel flying leads, among others [3]. - Koil's experienced team is capable of supporting subsea engineering, manufacturing, installation, commissioning, and maintenance projects globally [3].

Core Insights - Loblaw has released its February Food Inflation Report, providing insights into factors affecting food prices and future expectations [1] Group 1: Inflation Trends - Inflation showed a slight decrease in February, with the overall Consumer Price Index (CPI) at 1.8%, down from 2.3% in January [2] - The price of food purchased from stores decreased by 70 basis points from January, now at 4.1% [2] - In contrast, the price of food purchased from restaurants increased by 7.8% in February, marking a significant rise, especially following the previous year's increase after the GST/HST holiday ended in February 2025 [2]

Core Viewpoint - Kaldalón hf. held its Annual General Meeting on March 26, 2026, where several key proposals were unanimously approved, including financial statements, dividend payments, board elections, and share capital reduction. Financial Statements and Profit Allocation - The 2025 Annual Financial Statements were confirmed and approved, with a dividend of ISK 1,000,000,000 proposed, equating to ISK 0.94 per share [2]. Board of Directors and Committees - Five individuals were elected to the Board of Directors, with Ásgeir Helgi Reykfjörð Gylfason appointed as Chairman and Haukur Guðmundsson as Vice Chairman [4]. - The Nomination Committee was elected unopposed, consisting of Ásgeir Sigurður Ágústsson, Margrét Sveinsdóttir, and Unnur Lilja Hermannsdóttir [11]. - Harpa Vífilsdóttir was elected as an external member of the Audit Committee [12]. Auditor Appointment - PricewaterhouseCoopers ehf. was unanimously approved as the Company's auditor for the upcoming financial year [5]. Remuneration Decisions - Board members will receive ISK 400,000 per month, with the Chairman earning double and the Vice Chairman earning one and a half times that amount [6]. - Audit Committee members will receive ISK 75,000 per month, while the Chairman will earn ISK 150,000 per month [7]. - Nomination Committee members will receive ISK 800,000 per term, with the Chairman earning ISK 1,100,000 per term [8]. - No separate remuneration will be provided for members of the Remuneration Committee [9]. - The Company's Remuneration Policy was approved unchanged from the previous year [10]. Share Capital and Buyback Authorization - The share capital will be reduced by ISK 242,918,180 through the cancellation of 24,291,818 treasury shares, amending the Articles of Association to reflect a new share capital of ISK 10,615,265,260 [13]. - The Board of Directors was authorized to purchase the Company's own shares until June 30, 2027, with specific conditions outlined for the repurchase program [14][15].